These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8494994

  • 21. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.
    Jorieux S, Gaucher C, Goudemand J, Mazurier C.
    Blood; 1998 Dec 15; 92(12):4663-70. PubMed ID: 9845532
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ.
    Thromb Haemost; 2007 Jun 15; 97(6):922-30. PubMed ID: 17549293
    [Abstract] [Full Text] [Related]

  • 27. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
    Wang Y, Zhang J, Wan H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar 15; 20(3):117-9. PubMed ID: 11601234
    [Abstract] [Full Text] [Related]

  • 28. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
    Hilbert L, Nurden P, Caron C, Nurden AT, Goudemand J, Meyer D, Fressinaud E, Mazurier C, INSERM Network on Molecular Abnormalities in von Willebrand Disease.
    Thromb Haemost; 2006 Sep 15; 96(3):290-4. PubMed ID: 16953269
    [Abstract] [Full Text] [Related]

  • 29. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
    Nesbitt IM, Hampton KK, Preston FE, Peake IR, Goodeve AC.
    Thromb Haemost; 1999 Sep 15; 82(3):1061-4. PubMed ID: 10494764
    [Abstract] [Full Text] [Related]

  • 30. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
    Ishimaru F, Hayashi H, Fujita T, Tsurumi N, Tsuda T, Kimura I.
    Rinsho Ketsueki; 1990 Sep 15; 31(9):1493-8. PubMed ID: 2246822
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC, Castaman G, Kamphuisen PW, Rosendaal FR, Bertina RM.
    Thromb Haemost; 2002 Feb 15; 87(2):252-7. PubMed ID: 11859851
    [Abstract] [Full Text] [Related]

  • 35. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr 15; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

  • 36. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.
    Thromb Haemost; 2000 Feb 15; 83(2):274-81. PubMed ID: 10739386
    [Abstract] [Full Text] [Related]

  • 37. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
    Schwarz HP, Schlokat U, Mitterer A, Váradi K, Gritsch H, Muchitsch EM, Auer W, Pichler L, Dorner F, Turecek PL.
    Semin Thromb Hemost; 2002 Apr 15; 28(2):215-26. PubMed ID: 11992244
    [Abstract] [Full Text] [Related]

  • 38. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J.
    Haematologica; 1998 Nov 15; 83(11):1009-14. PubMed ID: 9864923
    [Abstract] [Full Text] [Related]

  • 39. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
    Penas N, Pérez-Rodríguez A, Torea JH, Lourés E, Noya MS, López-Fernández MF, Batlle J.
    Am J Hematol; 2005 Nov 15; 80(3):188-96. PubMed ID: 16247740
    [Abstract] [Full Text] [Related]

  • 40. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
    Meyer D, Obert B, Pietu G, Lavergne JM, Zimmerman TS.
    J Lab Clin Med; 1980 Apr 15; 95(4):590-602. PubMed ID: 6965697
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.